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dan321@126.comAbstract A high performance liquid chromatographic method was developed and validated for
the quantitative determination of catechin in rat plasma and its pharmacokinetic study after
intragastric administration of Catechu and Xiongdanjiangre Wan into SD rats. Plasma samples
were prepared by protein precipitation using methanol–5% aqueous zinc sulfate (70:30, v/v) as
precipitant. Chromatographic separation was achieved on Hypersil C18 column (250 mm 4.6 mm,
10 mm) with acetonitrile–water–triethylamine (6:94:0.3, v/v/v, pH 4.070.1, adjusted with phos-
phoric acid) as mobile phase, followed by a UV detection at 207 nm. Good linearity was obtained
over the range of 0.143–7.15 mg/L of catechin, with correlation coefﬁcient of 0.9992. The method
was simple, sensitive, accurate and reproducible and has been successfully applied to the
pharmacokinetic study of catechin in rat plasma.
& 2011 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Xiongdanjiangre Wan was made of seven Chinese crude drugs,
mainly including Catechu, fel ursi and Rhubarb. It has been
widely used in deintoxication and purgation. Catechu, one ofersity. Production and hosting
n Jiaotong University.
sevier
(D. Zhang).the basic composition units of this compound preparation, has
already been recorded in Chinese Pharmacopoeia (2010 Edi-
tion) and been used to treat eczema, bleeding wound, aphtha
and so on. Catechin (Fig. 1) is one of the active components in
Catechu and Xiongdanjiangre Wan. Previous studies also
revealed that catechin showed strong activities of anti-athero-
sclerosis, antibiosis, anticancer and antioxidant [1–3].
A number of analytical techniques have been applied to the
quantiﬁcation and pharmacokinetic study of catechin in rabbit
plasma and rat plasma [4,5]. Only a few studies on pharmaco-
kinetic of catechin in different formulations have been reported
[6]. But there is no literature report on the quantiﬁcation and
pharmacokinetic study of catechin in rat plasma after intragas-
tric administration of Catechu and Xiongdanjiangre Wan. Since
catechin possesses various biological effects, it is necessary to
examine the difference on pharmacokinetic of catechin between
Catechu and Xiongdanjiangre Wan after intragastric adminis-
tration. In this study, a simple HPLC method with a simple
OOH
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OH
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Figure 1 Chemical structures of catechin.
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chin in rat plasma was developed, and was successfully applied
to the pharmacokinetic study of catechin in rat plasma.2. Experimental
2.1. Materials, chemicals and reagents
Xiongdanjiangre Wan and Catechu were provided by West
China School of Pharmacy (Sichuan University, Chengdu,
China). The reference standard of catechin was purchased
from the National Institute for the Control of Pharmaceutical
and Biological Products (Beijing, China). HPLC-grade acet-
onitrile was obtained from Fisher Scientiﬁc (Pittsburgh, PA,
USA). Other reagents were all of analytical grade. Ultra-pure
water was generated by using a water-puriﬁcation system
(PFC-10, Pin Cheng, Chengdu, China).2.2. Animals
Healthy SD rats (180–200 g, grade: CV, production license
No.: SCXK (Chuan) 2009-09, animal use license No.: SYXK
(Chuan) 2009-045) were purchased from the Experimental
Animal Center of Sichuan University. The rats were free to
water and fed with a standard laboratory diet before the
experiment. Animal experiments were conducted in accor-
dance with the Guidelines provided by the Institutional Ethics
Committee for Care and Use of Laboratory Animal of
Sichuan Province and protocols approved by the Animal Care
Committee of Sichuan University.2.3. LC instruments and analytical conditions
Chromatography analysis was performed on an LC-10ATvp
LC chromatograph (Shimadzu, Japan) with an SPD-10Avp
UV–vis detector (Shimadzu, Japan) and a column oven. The
detector was operated at 207 nm. The analytical column was a
Hypersil C18 column (250 mm 4.6 mm, 10 mm, Dalian Elite
Analytical Instruments Co. Ltd., Dalian, China). The chro-
matographic data was processed by a Chromtek software
(version 5.3, Alltech, USA). All analyses were conducted in
isocratic mode, the mobile phase consisted of acetonitrile–
water–triethylamine (6:94:0.3, v/v/v, pH 4.070.1, adjusted
with phosphoric acid) with a ﬂow rate of 1.0 mL/min and
column temperature of 35 1C.2.4. Preparation of standard solution and working reference
solution
Standard solution was prepared by weighing proper amounts
of the catechin reference standard and dissolving it in
methanol (24 mg/L). In order to obtain a true result reﬂecting
the inﬂuence of coexisting compounds, the Xiongdanjiangre
Wan stock extract, in which the content of catechin had been
standardized by corresponding standard solution, was diluted
to a certain concentration and used as the working reference
solution instead of standard solution. An accurately weighed
ﬁne powder (1.0 g, through a 20-mesh sieve) of Xiongdanjian-
gre Wan was extracted with methanol (50 mL) for 20 min of
ultrasonication, and then ﬁltered. The ﬁltrate was used as the
stock extract. A diluted extract was prepared by diluting the
stock extract to its 10 percent of concentration. An aliquot of
5 mL of the diluted extract and standard solution of catechin
(24 mg/L) was injected into the HPLC system for analysis,
and then the concentration of catechin in the diluted extract
was obtained (28.6 mg/L) and that in the working reference
stock solution was also calculated (286 mg/L). The working
reference solution was prepared by diluting the working
reference stock solution into the concentration of 0.715 mg/L
and stored at 4 1C.
2.5. Preparation of calibration samples and quality control
samples
Different volumes (10, 30, 50, 200, 300 and 500 mL) of the
working reference solution were dried by nitrogen gas and
then mixed with 50 mL blank rat plasma, respectively. The
ﬁnal concentrations of catechin in calibration samples were
0.143, 0.429, 0.715, 2.86, 4.29 and 7.15 mg/L. Quality control
(QC) samples were generated with the same process to yield
ﬁnal three different concentrations levels (0.429, 2.86 and
7.15 mg/L). All the samples were stored at 4 1C and brought to
room temperature before use.
2.6. Preparation of Catechu suspension and Xiongdanjiangre
Wan suspension
Catechu suspension was prepared as follows: about 10.0 g
Catechu crude herb was crushed to powder, and then was
sifted through a 20-mesh (0.9 mm) sieve. 1.0 g powder was
extracted with water (50 mL) in a heating–reﬂuxing bath for
1 h after soaked for 24 h. And the extract was ﬁltered. The
ﬁltrate was evaporated to dryness and the residue was
dissolved in 50 mL water (0.02 g/mL Catechu powder in
water).
Xiongdanjiangre Wan suspension was prepared as follows:
6.0 g of Xiongdanjiangre Wan powder (prepared in the same
way of Catechu powder) was weighed, and prepared as the
procedure of Catechu suspension, giving an equal content of
Catechu to the catechu suspension.
2.7. Preparation of plasma samples
A mixture consisting of 50 mL of plasma sample, 10 mg of
sodium ﬂuoride and 100 mL of methanol–5% aqueous zinc
sulfate (70:30, v/v) was vortex-mixed for 5 min and then
centrifuged for 10 min at 12,000 rpm. An aliquot of 10 mL of
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determination of catechin.
2.8. Pharmacokinetic study
The rats were randomly divided into two groups (I and II ) in
half respectively male and female. An aliquot of 2.5 mL of
Catechu suspension was administered to group I, while the
same volume of Xiongdanjiangre Wan suspension to group II.
Serial blood samples (0.5 mL) were collected into heparinized
tubes from the vena caudalis at 0.25, 0.5, 0.75, 1, 1.5, 2.5, 3.5,
5, 7, 10, 12 and 24 h. Samples were immediately centrifuged at
12,000 rpm for 10 min and stored at 20 1C until analysis.
The pharmacokinetic parameters of catechin were calculated
by DAS 2.1 software.3. Results and discussion
3.1. Optimization of plasma sample pretreatment conditions
Catechin is a strongly polar compound, and can be dissolved
in methanol and acetonitrile easily. Therefore, a simple protein
precipitation procedure was available to prepare the plasma
samples. The calibration sample with a concentration of
2.86 mg/L of catechin was used as a typical one to do the
optimization. Methanol, acetonitrile and methanol–5% aqu-
eous zinc sulfate (70:30, v/v) were investigated as the pre-
cipitants. Methanol-5% aqueous zinc sulfate (70:30, v/v) wasFigure 2 Typical chromatograms of a blank rat plasma (A), blank ra
sample 45 min after intragastric administration of Catechu suspe
administration of Xiongdanjiangre Wan suspension (D). 1, catechin.chosen as the precipitant for the highest value of peak area.
Three governing parameters: precipitant volume (the different
ratios of selected precipitant and blank plasma: 2:1, 1:1 and
1:2), balance time for the conjugation between drug and
protein (15, 30 and 45 min), and the amount of enzyme
inhibitor (Sodium Fluoride; none, 5, 10 and 20 mg) were
optimized by univariate approach. When the volume of
methanol-5% aqueous zinc sulfate (70:30, v/v) was 2 times
of that of plasma, balance time was approximately 30 min and
sodium ﬂuoride was 10 mg, the peak area of catechin reached
the highest value. Therefore, the best pretreatment conditions
of plasma samples were as follows: plasma samples (50 mL)
spiked with 10 mg sodium ﬂuoride, 100 ml methanol–5%
aqueous zinc sulfate (70:30, v/v) and equilibrated for 30 min.
3.2. Method validation
3.2.1. Speciﬁcity
The speciﬁcity of the method to analyze catechin in the
presence of other endogenous substances in plasma was
investigated. Fig. 2 shows that the resolution factor measured
for the peaks from the nearest peak in plasma was at least
equal to 1.5 under optimized chromatographic conditions.
3.2.2. Linearity and LLOQ
The calibration curve was constructed by plotting the
peak areas versus the concentrations of catechin (range from
0.143–7.15 mg/mL) in standard plasma samples at sixt plasma spiked with working reference solution (B), a rat plasma
nsion (C) and a rat plasma sample 45 min after intragastric
L. Xie et al.300concentration levels. The lower limit of quantiﬁcation (LLOQ)
was set as the lowest concentration on the calibration curve.
Good linearity was obtained with the equation of Y¼9.561
103Xþ831.6 with correlation coefﬁcient of 0.9992. The LLOQ
was 0.143 mg/mL, suggesting a good sensitivity of the method.3.2.3. Precision
In this study, the precision was measured by means of intra-day
and inter-day precision. Intra-day precision was evaluated by
replicate determinations (n¼5) of catechin in QC samples at
different concentrations on the same day, whereas inter-day
precision was estimated on three different days. The measured
concentrations of catechin were calculated based on linearity plots.
In all situations, the relative standard deviation (RSD) values were
less than 5% (Table 1), which was considered to be acceptable.3.2.4. Accuracy
The recovery of the method was determined by analyzing the
percentage recovery of catechin in plasma samples. This
experiment was carried out by analyzing replicates (n¼3) at
three QC levels. The deviation between the measured value
and the true value was evaluated by the relative standard
deviation (RSD). As a result, the average recovery of catechin
was 95.4% with RSD of 1.66%, conﬁrming that the method
was accurate.3.0
3.5
4.0
/L
) Catechu Xiongdanjiangre Wan3.2.5. Stability
The stability of the working reference solution was evaluated
at 4 1C over 30 days. Short-term (at room temperature over
4 h), long-term (at 20 1C for 30 days), and two freeze-thaw
cycles stability had been evaluated by analyzing replicates
(n¼3) at three QC levels. The working reference solution was
stable in 30 days and the RSD of peak areas was 1.87. The
stability results of spiked plasma are shown in Table 2, which
indicated that catechin had no signiﬁcant degradation under
the conditions previously described.Table 2 Stability of catechin in rat plasma.
Spiked
concentration
(mg/L)
Short-term stability Long-
Mean7SD RSD
(%)
Mean
0.429 0.47070.008 1.59 0.4597
2.86 2.7970.06 2.19 2.727
7.15 7.1670.13 1.8 7.067
Table 1 Precision of catechin in rat plasma.
Spiked
concentration
(mg/L)
Intra-day precision
(n¼5)
Inter-day precision
(n¼5)
Mean7SD
(mg/L)
RSD
(%)
Mean7SD
(mg/L)
RSD
(%)
0.429 0.42770.590 1.4 0.42770.900 2.1
2.86 2.8773.90 1.4 2.8474.62 1.6
7.15 7.1575.26 0.7 7.1377.95 1.13.3. Pharmacokinetic application
The developed and validated LC method was applied to a
pharmacokinetic study of catechin in rats after intragastric
administration of Catechu and Xiongdanjiangre Wan contain-
ing equal amounts of Catechu. The plasma concentrations of
catechin at different points are expressed as mean7SD, and
the mean concentration–time curve is shown in Fig. 3. The
calculated pharmacokinetic parameters are summarized in
Table 3. The results showed that catechin behaved as an opened
two-compartment model after intragastric administration of the
suspension of Catechu and that of Xiongdanjiangre Wan. The
data showed that the absorption and distribution of catechin
were very fast, with Tmax of 45 min. The elimination halftime
(T1/2b) of catechin in Catechu was longer than that in Xiong-
danjiangre Wan and the relative bioavailability (AUC0N) of
catechin in Catechu was higher than that in Xiongdanjiangre
Wan. There were signiﬁcant differences in CL and relative
bioavailability (AUC0N) of catechin between Catechu and
Xiongdanjiangre Wan, respectively. The elimination time was
shorter and the AUC0N was lower for catechin after intragas-
tric administration of Xiongdanjiangre Wan than those of
Catechu. These results demonstrated that Xiongdanjiangre
Wan did not increase the bioavailabilities of catechin in vivo,
compared with Catechu, and the mechanism of this difference
needs further study.4. Conclusion
An effective, rapid and reliable HPLC method was developed
for the determination of catechin in rat plasma. The method
was proved to be simple, special, precise and accurate, and hasterm stability Freeze-thaw stability
7SD RSD
(%)
Mean7SD RSD
(%)
0.014 3.01 0.47170.022 4.62
0.09 3.49 2.7270.12 4.22
0.15 2.14 7.1170.16 2.19
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Figure 3 Mean plasma concentrations of catechin vs. time proﬁle
in six rats after intragastric administration of Catechu (m) and
Xiongdanjiangre Wan (&).
Table 3 Pharmacokinetic parameters of catechin after
intragastric administration of Catechu and Xiongdanjian-
gre Wan (n¼6, mean7SD).
Parameters Catechu Xiongdanjiangre
Wan
T1/2a (h) 1.83271.961 0.49970.260
T1/2b (h) 12.43374.036 7.77972.568
AUC0N (mg/L h) 16.70472.360 7.44471.176
Cmax (mg/L) 3.38770.638 1.66670.184
Tmax (h) 0.7570 0.7570
CL/F (L/h/kg) 3.72070.617 7.99371.540
Determination and pharmacokinetic study of catechin by HPLC 301been successfully applied to determine the pharmacokinetic
parameters of catechin in rat plasma after intragastric admin-
istration of Catechu and Xiongdanjiangre Wan. The pharma-
cokinetic parameters obtained may be useful for the clinical
application and further studies of Catechu and its Chinese
medicinal preparations.References
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